Arrowstreet Capital, Limited Partnership Edwards Lifesciences Corp Transaction History

Arrowstreet Capital, Limited Partnership

$114 Billion
Q2 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 225,020 shares of EW stock, worth $15 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

225,020

Previous 857,006 73.74%

Holding current value

$15 Million

Previous $81.9 Million 74.62%

% of portfolio

0.02%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $53.3 Million - $59.6 Million	-631,986 Reduced 73.74%	225,020 $20.8 Million
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $14.9 Million - $19.6 Million	-204,778 Reduced 19.29%	857,006 $81.9 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $24.1 Million - $30.3 Million	-389,815 Reduced 26.85%	1,061,784 $81 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $45.2 Million - $60.9 Million	-652,500 Reduced 31.01%	1,451,599 $101 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $347,946 - $403,166	-4,274 Reduced 0.2%	2,104,099 $198 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $46.1 Million - $52.5 Million	-620,906 Reduced 22.75%	2,108,373 $174 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $20.4 Million - $26.1 Million	298,351 Added 12.27%	2,729,279 $204 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $30.1 Million - $39.2 Million	-365,613 Reduced 13.07%	2,430,928 $201 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $44.6 Million - $66.1 Million	-515,592 Reduced 15.57%	2,796,541 $266 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $5.21 Million - $6.56 Million	51,140 Added 1.57%	3,312,133 $390 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $75.4 Million - $92.6 Million	708,921 Added 27.78%	3,260,993 $422 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $111 Million - $132 Million	1,074,538 Added 72.73%	2,552,072 $289 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $42.9 Million - $53.7 Million	512,265 Added 53.07%	1,477,534 $153 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $74.1 Million - $85.4 Million	941,850 Added 4021.73%	965,269 $80.7 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $17.4 Million - $22.1 Million	-242,661 Reduced 91.2%	23,419 $2.14 Million
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $106 Million - $138 Million	-1,572,792 Reduced 85.53%	266,080 $21.2 Million
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $58.4 Million - $78.1 Million	1,015,022 Added 123.2%	1,838,872 $127 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $14.6 Million - $22.5 Million	278,114 Added 50.96%	823,850 $155 Million
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $39.1 Million - $44.8 Million	545,736 New	545,736 $127 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $1.45 Million - $1.78 Million	-23,593 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $5.32 Million - $6.14 Million	-95,387 Reduced 80.17%	23,593 $4.36 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $4.44 Million - $5.94 Million	92,675 Added 352.31%	118,980 $22.8 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $21.9 Million - $26.9 Million	-471,811 Reduced 94.72%	26,305 $4.03 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $3.04 Million - $3.86 Million	66,589 Added 15.43%	498,116 $86.7 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $4.55 Million - $5.5 Million	107,289 Added 33.09%	431,527 $62.8 Million
Q1 2018 May 14, 2018	BUY	$37.19 - $47.45 $7.81 Million - $9.97 Million	210,106 Added 184.09%	324,238 $45.2 Million
Q4 2017 Feb 09, 2018	SELL	$33.79 - $39.39 $15.8 Million - $18.4 Million	-467,910 Reduced 80.39%	114,132 $12.9 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $21.1 Million - $22.6 Million	582,042	582,042 $63.6 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Edwards Lifesciences Corp Transaction History